Interestingly, two cases of aPAP that developed during a course of RA [86] suggest that anti-GM-CSF autoAbs are produced to neutralize the increased GM-CSF and the failure of immune tolerance is essential. This evidence concerns the gene CSF2 and rheumatoid arthritis.